Literature DB >> 2324089

A ubiquitin-protein ligase specific for type III protein substrates.

H Heller1, A Hershko.   

Abstract

A previously studied species of ubiquitin-protein ligase contains specific sites for the binding of basic (Type I) and bulky hydrophobic (Type II) NH2-terminal amino acid residues of protein substrates. We now describe another enzyme that ligates ubiquitin specifically to proteins that have NH2-terminal residues other than the above two categories (Type III substrates). The new species of ligase, that we call E3 beta, is separable from the formerly described ligase (termed E3 alpha) by affinity chromatography on protein substrate columns. E3 beta was partially purified from extracts of rabbit reticulocytes and was shown to be required for the breakdown of Type III proteins. Apart from its different substrate specificity, it resembles E3 alpha in some physical properties, in a requirement for ubiquitin carrier protein (E2) for conjugate formation, and in its action to ligate multiple ubiquitin units to the substrate protein. The denatured derivative of bovine pancreatic ribonuclease is a specific substrate for E3 alpha, while that of ribonuclease S-protein is a good substrate for E3 beta. Since S-protein is formed by the removal from ribonuclease of NH2-terminal S-peptide, it is suggested that E3 beta interacts with an NH2-terminal determinant exposed in ribonuclease S-protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  [Ubiquitin-dependent degradation and modification of proteins].

Authors:  J von Kampen; M Wettern
Journal:  Naturwissenschaften       Date:  1992-04

Review 2.  Regulation by proteolysis: energy-dependent proteases and their targets.

Authors:  S Gottesman; M R Maurizi
Journal:  Microbiol Rev       Date:  1992-12

Review 3.  [Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis].

Authors:  W Hilt; D H Wolf
Journal:  Naturwissenschaften       Date:  1995-06

4.  Engineering in vivo instability of firefly luciferase and Escherichia coli beta-glucuronidase in higher plants using recognition elements from the ubiquitin pathway.

Authors:  C K Worley; R Ling; J Callis
Journal:  Plant Mol Biol       Date:  1998-05       Impact factor: 4.076

5.  Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway.

Authors:  Y T Kwon; Z Xia; I V Davydov; S H Lecker; A Varshavsky
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Phosphorylation of ubiquitin-activating enzyme in cultured cells.

Authors:  J C Cook; P B Chock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.

Authors:  V Sudakin; D Ganoth; A Dahan; H Heller; J Hershko; F C Luca; J V Ruderman; A Hershko
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

8.  Crystal structure of a ubiquitin-dependent degradation substrate: a three-disulfide form of lysozyme.

Authors:  C P Hill; N L Johnston; R E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.

Authors:  I Stancovski; H Gonen; A Orian; A L Schwartz; A Ciechanover
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu.

Authors:  H Gonen; C E Smith; N R Siegel; C Kahana; W C Merrick; K Chakraburtty; A L Schwartz; A Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.